Dabur India is under the scanner as three of its foreign subsidiaries are facing lawsuits in federal and state courts in the US and Canada. According to reports, it’s alleged that the company’s hair-relaxer products have led to ovarian cancer, and uterine cancer, besides causing other health-related issues.
Namaste Laboratories LLC, Dermoviva Skin Essentials Inc. and Dabur International Ltd are facing multiple lawsuits, claimed a late-night regulatory filing from the homegrown FMCG and Ayurvedic products maker.
These cases are in the pleadings and early discovery phases of litigation — the parties can contest the plaintiffs’ complaints and even request information and documents.
“Cases have been filed in both federal and state courts in the United States and Canada. The federal cases were consolidated as a Multi-District Litigation, also referred to as MDL, before the United States District Court for the Northern District of Illinois,” it was quoted as saying.
“Certain consumers in the hair relaxer product industry have alleged that some industry players or defendants sold and/or manufactured hair relaxer products that contain certain chemicals and that the use of these hair relaxer products has caused ovarian cancer, uterine cancer and other health issues in the users,” the firm informed.
About the financial implications owing to compensation, penalty etc, Dabur said at this stage of the litigation, any such implication “due to settlement or verdict outcome cannot be determined”.
Also Read: Nokia’s Response To Drop In Sales: Cut 14,000 Jobs
